MAIA Biotechnology, Inc. (MAIA)
NYSE: MAIA · Pharmaceutical Preparations · Chicago, IL · filing with the SEC since 2021
Who runs MAIA Biotechnology, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Vitoc Vlad
Chief Executive Officer. First filing Jul 2022, latest Sep 15, 2026, 21 filings in all.
Officers reporting now
3
of 9 people with a filing in the last fifteen months
Directors reporting now
6
12 people on the record since 2022
Officerssales are open-market, Oct 2, 2025 to Oct 2, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Vitoc Vlad | Chief Executive Officer | Jul 2022 | Sep 15, 2026 | none |
| Gryaznov Sergei | Chief Scientific Officer | Jul 2022 | Jun 2, 2026 | none |
| Himmelreich Jeffrey C | Head of Finance | Nov 2023 | Jun 1, 2026 | none |
Directorssales are open-market, Oct 2, 2025 to Oct 2, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Chaouki Steven M | director | Jul 2022 | Oct 2, 2026 | none |
| Guerrero Ramiro | director | Jul 2022 | Oct 2, 2026 | none |
| Louie Ngar Yee | director | Jul 2022 | Oct 2, 2026 | none |
| Luput Cristian | director | Jul 2022 | Oct 2, 2026 | none |
| Smith Stan | director | Jul 2022 | Oct 2, 2026 | none |
| Theagene Jean-Manasse | director | Mar 2023 | Oct 2, 2026 | none |
Earlier names on the record3, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.